Navigation Links
PDL BioPharma Announces Third Quarter 2011 Financial Results
Date:11/9/2011

INCLINE VILLAGE, Nev., Nov. 9, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the third quarter ended September 30, 2011.

(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)

RevenuesTotal revenues for the third quarter of 2011 were $83.8 million, compared to $86.4 million for the same period of 2010, a three percent year-over-year decrease. Total revenues for the nine months ended September 30, 2011, were $289.2 million, compared to $268.8 million for the same period of 2010, an eight percent increase.

The third quarter 2011 revenue decline is driven primarily by reduced royalties from second quarter 2011 sales of Avastin® partially offset by increased royalties from second quarter 2011 sales of Herceptin®, Lucentis® and Tysabri®. Also contributing to the decline is a lower average royalty rate on sales of Avastin, Herceptin, Lucentis and Xolair® (the Genentech Products) that are either made or sold in the United States (U.S.-based Sales) due to higher year-to-date sales in 2011. Sales of the Genentech Products are subject to a tiered royalty rate for U.S.-based Sales and a flat royalty rate of three percent for product that is manufactured and sold outside of the United States. Due to the tiering, in the second quarter of 2011, only 15% of U.S.-based Sales were above the lowest royalty rate of one percent as compared with 45% of U.S.-based Sales for the second quarter 2010. The net sales thresholds and the applicable royalty rates for product that is either made or sold in the United States are outlined below:   Royalty RateNet sales up to $1.5 billion

3.0%Net sales between $1.5 billion and $2.5 billion

2.5%Net sales between $2.5 billion and $4.0 billion

2.0%Net sales e
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
2. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
3. PDL BioPharma to Announce Third Quarter 2011 Financial Results on November 9, 2011
4. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
5. PAREXEL Expands Commercialization Capabilities With Dedicated Team to Help Biopharma Companies Demonstrate Product Value
6. Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
7. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
8. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
9. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
10. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
11. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced that ... of Lixte,s lead compound, LB‑100, is being conducted, has been ... S. Kovach , M.D., the founder and President of Lixte, ... at a single site. Accrual of patients, however, was slower ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... of Directors has approved a share repurchase program. The ... $300 million of Mallinckrodt plc ordinary shares. ... opportunities remain top priorities as we continue to pursue ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... DUBAI, UAE, February 8, 2012 In the ... diabetic; six countries in the MENA region are among the ... include the United Arab Emirates, Bahrain, Egypt, Kuwait, Oman and ... accounting for 14 percent of its total health care expenditure ...
... 7, 2012  Prometheus Laboratories Inc., a specialty pharmaceutical ... a research and collaboration agreement with an unnamed ... Prometheus, proprietary oncology diagnostic platform (CEER) to develop ... The CEER arrays may ultimately be used in ...
Cached Medicine Technology:Meeting of the Region's Top Diabetes Experts in Dubai this March 2Prometheus Signs Research & Collaboration Agreement with Leading Worldwide Pharmaceutical Company 2
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... 2015 The federal court overseeing thousands of ... Court, Southern District of West Virginia has upheld a $2 ... first bellwether trial. In an Order dated January 21st, the ... finding that C.R. Bard had not proven a miscarriage of ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... back to the cancer communities in the cities visited ... Society for Therapeutic Radiology and Oncology (ASTRO) is partnering ... of cancer survivorship. The Kenneth B. Schwartz Center conducts ... the art of compassionate healthcare. , The Kenneth B. ...
... instances of Salmonella poisoning linked to a jalapeno pepper in Texas, ... sweating it out over the jalapeno crisis do not have to ... Resource reveals some fiery competition. , ... LENEXA, ...
... of articles and magazine covers talk about retirement, but the fact is ... By 2010, 58 million people--20% of the population--will be 50-64. ... survive and thrive in this challenging PreRetirement life stage? , ... (PRWEB) ...
... of Public Health Confirms Positive Review ... of DNA ... it received a formal letter from the California Department of Public,Health (CDPH) ... letter states that DNA Direct,s tests are,performed only with a physician order ...
... Inc. (Amex: ADK ), an Ohio based long ... refinancing of one of its nursing,homes in Ohio., ... single story nursing home,facility located in Greenfield, Ohio. Recently, ... of the art private bedrooms, along with a new,kitchen, ...
... Foundation to Provide Health Coverage Eligibility Screening and ... Application Assistance to Uninsured, ... wholly funded by WellPoint, Inc., has,awarded The CoverMe Foundation a ... in identifying and assisting uninsured persons,and families in finding and ...
Cached Medicine News:Health News: No More Jalapenos? No Problemo! Salmonella-Free Alternatives : No More Jalapenos? No Problemo, yes Poblano! 2Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 2Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 3Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 4Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 5Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 6Health News:Surviving Your PreRetirement Years: 15 Things You Must Do Between 50 and 64 7Health News:DNA Direct Confirms It Is Operating in Compliance with California State Laboratory Law 2Health News:AdCare Health Systems, Inc. Announces the Refinancing of a Nursing Home in Ohio 2Health News:WellPoint Foundation Awards $2.5 Million Grant to The CoverMe Foundation 2Health News:WellPoint Foundation Awards $2.5 Million Grant to The CoverMe Foundation 3
... of the outstanding features of our Neomax ... Molding Technology. , This manufacturing process allows ... controls the bunching and irritation in the ... wearer. , ,Colors available: Blue, ...
... Flex™ might just be the world's most ... functional support, post-op/rehab support, or both, Flex ... new Accutrac™ ROM hinges control flexion and ... long-term durability while being heat-moldable to accommodate ...
... Donut is a neoprene alternative, constructed ... polyester Lycra Fabric that allows for ... provides for patellar control. Ideal for ... or irritations. Click here to view ...
... of the TROM provides the same easy ... as the full foam TROM, but is ... of use and versatility of the Cool ... following major ligament surgery, meniscal repairs, patella ...
Medicine Products: